Last reviewed · How we verify
Lu AG13909
At a glance
| Generic name | Lu AG13909 |
|---|---|
| Sponsor | H. Lundbeck A/S |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia (PHASE1, PHASE2)
- A Trial of Lu AG13909 in Adult Participants With Cushing's Disease (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |